Hi uiux
I am sure knowing how well you catalogue BRN information you will be able to find the reference to the presentation when the CEO said that for obvious reasons they would not speak publicly about the quantum of IP licence fees as this was not in the companies interest as basically they will have different rates depending who they are dealing with and the purpose for which the IP is being used including the volume of sales and the like.
The important thing apart from your astute observation is the size of this company and the scope of product it produces which would have AKIDA technology potential applications.
AKIDA Ballista - NASA and WOW a double whammy for Christmas.
And uiux a big thank you for all your assistance to myself and other posters here over many years. Have a great Christmas you deserve it.
FF.
- Forums
- ASX - By Stock
- BRN
- Ann: First Akida IP License Agreement
Ann: First Akida IP License Agreement, page-59
-
-
- There are more pages in this discussion • 724 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BRN (ASX) to my watchlist
|
|||||
Last
17.0¢ |
Change
-0.005(2.86%) |
Mkt cap ! $333.0M |
Open | High | Low | Value | Volume |
18.0¢ | 18.0¢ | 16.8¢ | $1.174M | 6.869M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 185137 | 17.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.5¢ | 920196 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 185137 | 0.170 |
59 | 1704182 | 0.165 |
70 | 1482354 | 0.160 |
24 | 1146919 | 0.155 |
75 | 1949972 | 0.150 |
Price($) | Vol. | No. |
---|---|---|
0.175 | 920196 | 12 |
0.180 | 1575617 | 38 |
0.185 | 1198216 | 25 |
0.190 | 1209016 | 21 |
0.195 | 914971 | 14 |
Last trade - 16.10pm 13/08/2024 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online